7801 - 7850 of 8586 Results
Title
Year
-
RESTRICTEDTitle: An mGlu4‐PositiveAllostericModulatorAlleviatesParkinsonism inPrimatesJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1619End Page: 1631Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27462Citation Count: 52
-
OPENTitle: Bridging a mechanistic gap from diet to synapsesJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 120Issue #: 33Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2309992120Best OA location URL: https://oskar-bordeaux.fr/handle/20.500.12278/184699Citation Count: 1
-
RESTRICTEDTitle: Cough and Swallowing Therapy and Their Effects on Vocal Fold Bowing and Laryngeal LesionsJournal Name: The LaryngoscopePublisher: WileyVol: 134Issue #: 3Start Page: 1127End Page: 1132Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/lary.30922Citation Count: 4
-
OPENTitle: PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista JunctionsJournal Name: Molecular CellPublisher: Elsevier BVVol: 69Issue #: 5Start Page: 744End Page: 756.e6Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2018.01.026Best OA location URL: http://www.cell.com/article/S1097276518300558/pdfCitation Count: 100
-
OPENTitle: The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced DyskinesiaJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 1Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22010020Best OA location URL: https://www.mdpi.com/1422-0067/22/1/20/pdf?version=1608635348Citation Count: 9
-
OPENTitle: Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 97Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.27158Best OA location URL: https://escholarship.org/content/qt5vs9p83m/qt5vs9p83m.pdfCitation Count: 4
-
OPENTitle: Personalised regional modelling predicts tau progression in the human brainJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 23Issue #: 7Start Page: e3003241End Page: e3003241Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3003241Best OA location URL: https://doi.org/10.1371/journal.pbio.3003241Citation Count: 0
-
OPENTitle: Neuronal α‐Synuclein Disease Stage Progression over 5 YearsJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 7Start Page: 1318End Page: 1330Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.30191Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30191Citation Count: 2
-
OPENTitle: Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 1Start Page: 96End Page: 104Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25376Citation Count: 36
-
RESTRICTEDTitle: Thalamic deep brain stimulation for drug-induced tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 21Issue #: 11Start Page: 1369End Page: 1370Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.08.033Citation Count: 7
-
RESTRICTEDTitle: α-synuclein overexpression and the microbiome shape the gut and brain metabolome in miceJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00816-wBest OA location URL: https://www.nature.com/articles/s41531-024-00816-w.pdfCitation Count: 2
-
OPENTitle: Neuroimmunology of the Interleukins 13 and 4Journal Name: Brain SciencesPublisher: MDPI AGVol: 6Issue #: 2Start Page: 18End Page: 18Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci6020018Best OA location URL: https://www.mdpi.com/2076-3425/6/2/18/pdf?version=1465804812Citation Count: 102
-
OPENTitle: Identifying individuals at-risk of developing Parkinson’s disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel StudyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01008-wCitation Count: 0
-
OPENTitle: Tissue specific LRRK2 interactomes reveal a distinct striatal functional unitJournal Name: PLOS Computational BiologyPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 1Start Page: e1010847End Page: e1010847Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pcbi.1010847Best OA location URL: https://doi.org/10.1371/journal.pcbi.1010847Citation Count: 9
-
OPENTitle: White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patientsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 20Issue #:Start Page: 892End Page: 900Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2018.09.025Best OA location URL: https://doi.org/10.1016/j.nicl.2018.09.025Citation Count: 66
-
RESTRICTEDTitle: Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 110Issue #:Start Page: 125End Page: 134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2016.07.025Citation Count: 26
-
OPENTitle: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin AmericaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 8Start Page: 629End Page: 631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003Best OA location URL: https://repositorio.uchile.cl/handle/2250/165323Citation Count: 17
-
OPENTitle: Understanding what aspects of Parkinson’s disease matter most to patients and familiesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-71555-4Best OA location URL: https://www.nature.com/articles/s41598-024-71555-4.pdfCitation Count: 8
-
OPENTitle: Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0245-9Best OA location URL: http://link.springer.com/content/pdf/10.1186/s13024-018-0245-9.pdfCitation Count: 65
-
RESTRICTEDTitle: Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse ModelJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 881End Page: 892Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.26600Citation Count: 5
-
RESTRICTEDTitle: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490Citation Count: 7
-
RESTRICTEDTitle: PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathologyJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 12Start Page: 1961End Page: 1965Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27523Citation Count: 43
-
RESTRICTEDTitle: What Parkinson's disease patients say in their own words about their mood and anxiety symptomsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 130Issue #:Start Page: 107190End Page: 107190Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107190Citation Count: 0
-
RESTRICTEDTitle: Singing in groups for Parkinson's disease (SING-PD): A pilot study of group singing therapy for PD-related voice/speech disordersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 18Issue #: 5Start Page: 548End Page: 552Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.02.009Citation Count: 65
-
OPENTitle: Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 120Issue #:Start Page: 107End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.004Citation Count: 125
-
OPENTitle: A beginner’s guide into curated analyses of open access datasets for biomarker discovery in neurodegenerationJournal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-023-02338-1Best OA location URL: https://www.nature.com/articles/s41597-023-02338-1.pdfCitation Count: 1
-
OPENTitle: RTP801 mediates transneuronal toxicity in culture via extracellular vesiclesJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 12Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jev2.12378Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12378Citation Count: 3
-
OPENTitle: Nilotinib – Differentiating the Hope from the HypeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 3Start Page: 519End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160904Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160904?id=journal-of-parkinsons-disease%2Fjpd160904Citation Count: 29
- Additional feedforward mechanism of Parkin activation via binding of phospho-UBL and RING0 in trans2024OPENTitle: Additional feedforward mechanism of Parkin activation via binding of phospho-UBL and RING0 in transJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.96699.3Best OA location URL: https://cdn.elifesciences.org/articles/96699/elife-96699-v1.pdfCitation Count: 2
-
OPENTitle: Autophagic stress activates distinct compensatory secretory pathways in neuronsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 122Issue #: 28Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2421886122Best OA location URL: https://www.pnas.org/doi/pdf/10.1073/pnas.2421886122Citation Count: 1
-
OPENTitle: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 69Issue #:Start Page: 102474End Page: 102474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474Best OA location URL: http://www.thelancet.com/article/S2589537024000531/pdfCitation Count: 9
-
OPENTitle: An Anatomically Resolved Mouse Brain Proteome Reveals Parkinson Disease-relevant PathwaysJournal Name: Molecular & Cellular ProteomicsPublisher: Elsevier BVVol: 16Issue #: 4Start Page: 581End Page: 593Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1074/mcp.m116.061440Best OA location URL: https://www.mcponline.org/content/mcprot/16/4/581.full.pdfCitation Count: 66
-
OPENTitle: Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disordersJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-022-01468-8Best OA location URL: https://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-022-01468-8Citation Count: 58
-
OPENTitle: Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model ofParkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 77Issue #: 6Start Page: 930End Page: 941Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.24375Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6235675Citation Count: 49
-
OPENTitle: Spatial genomics of AAV vectors reveals mechanism of transcriptional crosstalk that enables targeted delivery of large genetic cargoJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41587-025-02565-4Best OA location URL: https://www.nature.com/articles/s41587-025-02565-4.pdfCitation Count: 5
-
RESTRICTEDTitle: Valbenazine as treatment for Huntington's disease choreaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 6Start Page: 459End Page: 460Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1Citation Count: 3
- Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinics2005RESTRICTEDTitle: Parkinson's disease and LRRK2: Frequency of a common mutation in U.S. movement disorder clinicsJournal Name: Movement DisordersPublisher: WileyVol: 21Issue #: 4Start Page: 519End Page: 523Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.20751Citation Count: 90
-
RESTRICTEDTitle: NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in ratJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 271Issue #:Start Page: 335End Page: 350Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2015.05.021Citation Count: 73
-
RESTRICTEDTitle: Depressive symptoms are associated with worse cognitive prognosis in patients with newly diagnosed idiopathic Parkinson diseaseJournal Name: PsychogeriatricsPublisher: WileyVol: 20Issue #: 6Start Page: 880End Page: 890Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/psyg.12601Citation Count: 18
-
RESTRICTEDTitle: Neuropsychological impairment in prodromal Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 371Issue #:Start Page: 117End Page: 120Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2016.10.007Citation Count: 14
-
OPENTitle: To be or not to be pink(1): contradictory findings in an animal model for Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/braincomms/fcz016Best OA location URL: https://academic.oup.com/braincomms/article-pdf/1/1/fcz016/33639299/fcz016.pdfCitation Count: 33
-
OPENTitle: A harmonized segmentation protocol for hippocampal and parahippocampal subregions: Why do we need one and what are the key goals?Journal Name: HippocampusPublisher: WileyVol: 27Issue #: 1Start Page: 3End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hipo.22671Best OA location URL: https://archive-ouverte.unige.ch/unige:111733Citation Count: 158
-
OPENTitle: An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 CohortsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 623End Page: 629Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191786Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191786?id=journal-of-parkinsons-disease%2Fjpd191786Citation Count: 43
- Pathway‐Specific Remodeling of Thalamostriatal Synapses in a Mouse Model of Parkinson's Disease2022OPENTitle: Pathway‐Specific Remodeling of Thalamostriatal Synapses in a Mouse Model of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 6Start Page: 1164End Page: 1174Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29030Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29030Citation Count: 11
-
OPENTitle: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemicJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 15Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.049755Best OA location URL: https://journals.biologists.com/dmm/article-pdf/doi/10.1242/dmm.049755/2392838/dmm049755.pdfCitation Count: 0
-
RESTRICTEDTitle: Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 22Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.22.1_supplement.103.2Citation Count: 0
-
OPENTitle: Alzheimer's disease: Pathogenesis and preventionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 3Start Page: 227End Page: 233Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2012.01.011Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2012.01.011Citation Count: 97
- Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons2018OPENTitle: Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine NeuronsJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 103Issue #: 6Start Page: 874End Page: 892Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.ajhg.2018.10.018Best OA location URL: http://www.cell.com/article/S0002929718303707/pdfCitation Count: 39
-
OPENTitle: Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activityJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 9Issue #: 11Start Page: 1295End Page: 1305Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.025684Best OA location URL: http://dmm.biologists.org/content/dmm/9/11/1295.full.pdfCitation Count: 61
-
OPENTitle: Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 2Start Page: 255End Page: 269Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26410Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9329215Citation Count: 20